{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:46:05Z","timestamp":1761561965458,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.carrev.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,1,29]],"date-time":"2015-01-29T02:34:11Z","timestamp":1422498851000},"page":"84-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis"],"prefix":"10.1016","volume":"16","author":[{"given":"Hideaki","family":"Ota","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Kitabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Torguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lowell F.","family":"Satler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William O.","family":"Suddath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto D.","family":"Pichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2015.01.004_bb0005","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2015.01.004_bb0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2015.01.004_bb0015","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1161\/CIRCULATIONAHA.105.552190","article-title":"Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice","volume":"112","author":"Dawkins","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.01.004_bb0020","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","article-title":"Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial","volume":"294","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2015.01.004_bb0025","first-page":"108","article-title":"Treatment of drug-eluting stent restenosis: an emerging challenge","volume":"74","author":"Aminian","year":"2009","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.01.004_bb0030","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.jacc.2010.03.026","article-title":"Treatment of drug-eluting stent restenosis the new pilgrimage: quo vadis?","volume":"55","author":"Alfonso","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0035","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1161\/01.CIR.0000130173.63105.4E","article-title":"Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes","volume":"109","author":"Lemos","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.01.004_bb0040","first-page":"9","article-title":"Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent","volume":"70","author":"Garg","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.01.004_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCINTERVENTIONS.111.963215","article-title":"Clinical outcomes and treatment after drug-eluting stent failure: the absence of traditional risk factors for in-stent restenosis","volume":"5","author":"Maluenda","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2015.01.004_bb0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2015.01.004_bb0055","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.carrev.2012.09.003","article-title":"Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses","volume":"13","author":"Markovic","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2015.01.004_bb0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.carrev.2013.09.006","article-title":"First- versus second-generation drug-eluting stents for the treatment of coronary bifurcations","volume":"14","author":"Costopoulos","year":"2013","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2015.01.004_bb0065","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jacc.2009.05.016","article-title":"The everolimus-eluting stent in real-world patients. 6-month follow-up of the X-SEARCH (Xience V stent evaluated at Rotterdam Cardiac Hospital) registry","volume":"54","author":"Onuma","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0070","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2011.07.031","article-title":"Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention. The EXCELLENT (Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial","volume":"58","author":"Park","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0075","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.jacc.2011.01.023","article-title":"Long-term comparison of everolimus-eluting and sirolimus-eluting stents for coronary revascularization","volume":"57","author":"R\u00e4ber","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0080","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.amjcard.2011.12.019","article-title":"Safety and efficacy of the XIENCE V everolimus-eluting stent compared to first-generation drug-eluting stents in contemporary clinical practice","volume":"109","author":"Waksman","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0085","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.109.905802","article-title":"Sirolimus-eluting stent versus balloon angioplasty for sirolimus-eluting stent restenosis: insights from the j-Cypher Registry","volume":"122","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2015.01.004_bb0090","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.amjcard.2006.07.027","article-title":"Comparison with conventional therapies of repeated sirolimus-eluting stent implantation for the treatment of drug-eluting coronary stent restenosis","volume":"98","author":"Kim","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0095","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.jacc.2011.11.047","article-title":"Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation","volume":"59","author":"Song","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0100","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2010.02.009","article-title":"Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents. The ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) Study","volume":"55","author":"Mehilli","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0105","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jcin.2012.03.017","article-title":"Implantation of a drug-eluting stent with a different drug (Switch strategy) in patients with drug-eluting stent restenosis. Results from a prospective multicenter study (RIBS III [Restenosis Intra-Stent: Balloon Angioplasty Versus Drug-Eluting Stent])","volume":"5","author":"Alfonso","year":"2012","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2015.01.004_bb0110","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijcard.2012.09.040","article-title":"Everolimus versus sirolimus-eluting stents for the treatment of sirolimus-eluting stent restenosis","volume":"165","author":"Yan","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0115","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00007890-199707150-00008","article-title":"SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo","volume":"64","author":"Schuler","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.carrev.2015.01.004_bb0120","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1111\/j.1540-8183.2009.00451.x","article-title":"XIENCE V\u2122 everolimus-eluting coronary stent system: a preclinical assessment","volume":"22","author":"Perkins","year":"2009","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0125","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jacc.2014.02.545","article-title":"Current treatment of in-stent restenosis","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0130","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jcin.2010.10.012","article-title":"Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis","volume":"4","author":"Habara","year":"2011","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2015.01.004_bb0135","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","article-title":"A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study","volume":"59","author":"Rittger","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0140","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomized, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2015.01.004_bb0145","series-title":"Presented at: TCT Washington DC, 13\u201317 September 2014, Late Breaking Clinical Trial","article-title":"A prospective, randomized trial of paclitaxel-eluting balloons versus everolimus-eluting stents in patients with coronary in-stent restenosis of drug-eluting stents: the RIBS IV clinical trial","author":"Alfonso","year":"2014"},{"key":"10.1016\/j.carrev.2015.01.004_bb0150","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1016\/j.jcin.2013.08.018","article-title":"Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel","volume":"7","author":"Naganuma","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2015.01.004_bb0155","first-page":"e11","article-title":"Bioresorbable vascular scaffold use in a case of in-stent restenosis","volume":"103","author":"Cadrin-Tourigny","year":"2014","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.carrev.2015.01.004_bb0160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.ihj.2014.05.016","article-title":"Bioresorbable vascular scaffold for coronary in-stent restenosis: a novel concept","volume":"66","author":"Deora","year":"2014","journal-title":"Indian Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838915000299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838915000299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:10:33Z","timestamp":1761559833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838915000299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1553838915000299"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2015.01.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of limus-eluting stents and balloon angioplasty for sirolimus-eluting in-stent restenosis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}